Armistice Capital, LLC 13D and 13G filings for Enlivex Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:27 pm Sale |
2025-03-31 | 13G | Enlivex Therapeutics Ltd. ENLV |
Armistice Capital, LLC | 1,781,931 7.530% |
-426,069 (-19.30%) |
Filing |
| 2025-02-14 5:43 pm Purchase |
2024-12-31 | 13G | Enlivex Therapeutics Ltd. ENLV |
Armistice Capital, LLC | 2,208,000 9.750% |
32,116 (+1.48%) |
Filing |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Enlivex Therapeutics Ltd. ENLV |
Armistice Capital, LLC | 2,175,884 9.990% |
2,175,884 (New Position) |
Filing |